Ascendis Pharma A/S SEC filings ASND
Ascendis Pharma A/S has 795 filings in SEC EDGAR's recent list, going back to Aug 1, 2014. Its latest annual report, Form 20-F, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 16, 2026 | Oct 16, 2026 |
| 6-K | Current report (foreign issuer) | Oct 14, 2026 | Oct 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 31, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 12, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 6-K | Current report (foreign issuer) | Jul 15, 2026 | Jul 15, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 29, 2026 | Jun 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 17, 2026 | Jun 17, 2026 |
| 6-K | Current report (foreign issuer) | Jun 15, 2026 | Jun 15, 2026 |
| 6-K | Current report (foreign issuer) | Jun 12, 2026 | Jun 12, 2026 |
| 6-K | Current report (foreign issuer) | Jun 10, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 3/A | Filing | Jun 1, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 26, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 22, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 11, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 7, 2026 | — |
| 6-K | Current report (foreign issuer) | May 7, 2026 | May 7, 2026 |
| 6-K | Current report (foreign issuer) | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 8-A12B/A | Filing | Apr 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 16, 2026 | Apr 15, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 7, 2026 | Apr 6, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 23, 2026 |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 17, 2026 | Mar 17, 2026 |
| 6-K | Current report (foreign issuer) | Mar 16, 2026 | Mar 16, 2026 |
| 6-K | Current report (foreign issuer) | Mar 11, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 144/A | Filing | Mar 6, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 5, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Feb 28, 2026 |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| 6-K | Current report (foreign issuer) | Feb 11, 2026 | Feb 11, 2026 |
| 20-F | Annual report (foreign issuer) | Feb 11, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 11, 2026 | Feb 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 3, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 14, 2026 |
| 144 | Notice of proposed sale | Jan 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 9, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Dec 30, 2025 | Dec 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 10, 2025 | Dec 10, 2025 |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 26, 2025 | Nov 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| 6-K | Current report (foreign issuer) | Oct 15, 2025 | Oct 15, 2025 |
| 6-K | Current report (foreign issuer) | Oct 8, 2025 | Oct 8, 2025 |
| 6-K | Current report (foreign issuer) | Sep 30, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Sep 10, 2025 | Sep 10, 2025 |
| 144 | Notice of proposed sale | Sep 9, 2025 | — |
| 144 | Notice of proposed sale | Aug 29, 2025 | — |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Jul 28, 2025 | Jul 28, 2025 |
| 6-K | Current report (foreign issuer) | Jul 9, 2025 | Jul 9, 2025 |
| 6-K | Current report (foreign issuer) | Jun 27, 2025 | Jun 27, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | Jun 9, 2025 | Jun 9, 2025 |
| 6-K | Current report (foreign issuer) | Jun 9, 2025 | Jun 9, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | May 28, 2025 | May 28, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 14, 2025 | — |
| 6-K | Current report (foreign issuer) | May 14, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 144 | Notice of proposed sale | May 7, 2025 | — |
| 144 | Notice of proposed sale | May 7, 2025 | — |
| 144 | Notice of proposed sale | May 6, 2025 | — |
| 144 | Notice of proposed sale | May 5, 2025 | — |
| 6-K | Current report (foreign issuer) | May 1, 2025 | May 1, 2025 |
| 6-K | Current report (foreign issuer) | May 1, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 29, 2025 |
| 6-K | Current report (foreign issuer) | Apr 9, 2025 | Apr 9, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Mar 28, 2025 |
| 6-K | Current report (foreign issuer) | Mar 20, 2025 | Mar 20, 2025 |
| 6-K | Current report (foreign issuer) | Mar 12, 2025 | Mar 12, 2025 |
| 144 | Notice of proposed sale | Mar 7, 2025 | — |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 144 | Notice of proposed sale | Feb 21, 2025 | — |
| 144 | Notice of proposed sale | Feb 20, 2025 | — |
| 144 | Notice of proposed sale | Feb 19, 2025 | — |
| 144 | Notice of proposed sale | Feb 19, 2025 | — |
| 144 | Notice of proposed sale | Feb 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 20-F | Annual report (foreign issuer) | Feb 12, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 12, 2025 | Feb 12, 2025 |
| 6-K | Current report (foreign issuer) | Feb 12, 2025 | Feb 12, 2025 |
| 6-K | Current report (foreign issuer) | Feb 12, 2025 | Feb 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 15, 2025 | Jan 15, 2025 |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 13, 2025 |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 13, 2025 |
| 6-K | Current report (foreign issuer) | Dec 30, 2024 | Dec 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 17, 2024 | Dec 17, 2024 |
| 6-K | Current report (foreign issuer) | Dec 12, 2024 | Dec 12, 2024 |
| 6-K | Current report (foreign issuer) | Dec 11, 2024 | Dec 11, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ASND (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Denmark
- Headquarters
- Hellerup
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1612042
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.